Cidara Therapeutics Inc (CDTX) stock news · rev $1.3M
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
This CDTX news page leads with what Cidara Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CDTX yet. We will not pad this page with generic market recap.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CDTX stock page; for the tape open the quote page.
Not investment advice.